Inventor

ROMERO F ANTHONY

US42 patents

⚠️ This page may combine multiple inventors who share the name “ROMERO F ANTHONY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ROMERO F ANTHONY

GENENTECH INC

Therapeutic compounds and uses thereof

Therapeutic compounds and uses thereof

Therapeutic compounds and compositions, and methods of use thereof

Therapeutic compounds and uses thereof

Therapeutic compounds and uses thereof

Therapeutic compounds and uses thereof

Pyrazolopyrimidine compounds and methods of use thereof

Therapeutic compounds and uses thereof

Therapeutic compounds and uses thereof

Pyrazolochlorophenyl compounds, compositions and methods of use thereof

Therapeutic compounds, compositions and methods of use thereof

Pyrazolopyrimidine aryl ether inhibitors of JAK kinases and uses thereof

Substituted pyrazolo[1,5-a]pyrimidines as inhibitors of JAK kinases

Therapeutic compounds and uses thereof

Therapeutic compounds and uses thereof

Therapeutic compounds and uses thereof

Therapeutic compounds and uses thereof

Therapeutic compounds and uses thereof

TERNS PHARMACEUTICALS INC

Compounds as GLP-1R agonists

Compounds as GLP-1R agonists

Compounds as GLP-1R agonists

Compounds as GLP-1R agonists

Compounds as GLP-1R agonists

Substituted benzamides as intermediates in the synthesis of inhibitors of tyrosine kinase enzymatic activity

Compounds as GLP-1R agonists

Compounds as GLP-1R agonists

(r)-n-(4-(chlorodifluoromethoxy)phenyl)-2-(difluoromethyl)-1-(1-hydroxypropan-2-yl)-7-(pyrimidin-5-yl)-1H-benzo[d]imidazole-5-carboxamide, or a pharmaceutically acceptable salt or tautomer thereof, for treating certain leukemias

Thyroid hormone receptor beta agonist compounds

Thyroid hormone receptor beta agonist compounds

TERNS INC

Thyroid hormone receptor beta agonist compounds

Thyroid hormone receptor beta agonist compounds

Substituted benzoimidazoles and imidazo[4,5-c]pyridines for treating certain leukemias

Tricyclic ASK1 inhibitors

UNITY BIOTECHNOLOGY INC

Peptide-based proteasome inhibitors for treating conditions mediated by senescent cells and for treating cancer

Peptide-based proteasome inhibitors for treating conditions mediated by senescent cells and for treating cancer

ORIC PHARMACEUTICALS INC

Polo like kinase 4 inhibitors

Polo like kinase 4 inhibitors

DANG QUN

Cyclic benzimidazole derivatives useful as anti-diabetic agents

Cyclic benzimidazole derivatives useful as anti-diabetic agents

DUFFY JOSEPH L

Spiroxazolidinone compounds

BOOKSER BRETT C

Cyclic benzimidazole derivatives useful as anti-diabetic agents

BAO JIANMING

Cyclic benzimidazole derivatives useful as anti-diabetic agents